High-throughput hazard screening provides an efficient and structured approach to identifying potential hazards early in the product development process and to supporting you with regulatory challenges.

Every project is unique. That’s why we offer customised screening strategies tailored to your specific objectives, regulatory context, and timelines. In addition, we develop user-friendly tools to ensure that results are clear, accessible, and aligned with your needs.

What we offer

  • We think along with you:
    We don’t just provide data, we partner with you to understand your challenges and find practical solutions that fit your business objectives.
  • Rapid screening at scale:
    Our high-throughput system quickly evaluates large numbers of substances (based on CAS numbers, IUPAC names, SMILES, etc.), giving you actionable insights without delays.
  • Check against known classifications and properties:
    We cross-reference substances with authoritative sources such as the ECHA CLP database and other regulatory databases to identify existing hazard classifications or known properties.
  • Hazard prediction models:
    User-friendly tools that combine hazard predictions from Quantitative Structure–Activity Relationship (QSAR) models using tools like the OECD QSAR Toolbox and VEGA models, ensuring robust and scientifically sound assessments.
  • Cutting-edge AI for (eco)toxicity predictions:
    AI tools are quickly becoming available for (eco)toxicity predictions. We are closely following along and integrating these tools into our services.

Hazard screening output for a list of compounds. The following hazards were screened: Persistence (P), Bioaccumulation (B), Toxicity (T), Mobility (M), Carcinogenicity (C), Mutagenicity (M), Reproductive toxicity (R) and Endocrine Disruptor (ED).

Why choose us?

Speed and efficiency:

High-throughput methods accelerate your decision-making.

Regulatory alignment:

Stay ahead of compliance requirement.

Innovation-driven:

Benefit from the lates AI and computation toxicology advancements.

Personalized solutions:

Get a screening approach that fits your business perfectly.

Contact our experts:

Karel Viaene, PhD

Karel Viaene

Senior Project Scientist
IBERA Diplomate

karel.viaene@arche-consulting.be
+ 32 9 216 70 34

More about Karel
Inge Huygens, PhD

Inge Huygens

Regulatory Affairs Manager

inge.huygens@arche-consulting.be

More about Inge